The PSI and ETH Zurich Center for Radiopharmaceutical Sciences covers the full range of activities for the production and clinical testing of medicinal radiocompounds.
Scientific Highlights
Using terbium against lymphoma
Promising laboratory experiments at PSI show that radionuclide therapy with the radioactive element terbium could combat lymphoma effectively.
Dr. Yingfang He has been honored with the Alavi-Mandell Award 2025
We congratulate Dr. Yingfang He for the excellent research work she did during her time at the Center for Radiopharmaceutical Sciences.
A superlative milestone
PSI spin-off Araris Biotech AG achieves valuation at unicorn-level!
IMPACT for Swiss society
World leader in muons and in production of medical radionuclides: The far-reaching significance of the planned upgrade.